SCOPUS 정보 검색 플랫폼

Volumn 8, Issue 4, 2009, Pages 235-

Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab

(2) Bambury, Richard a McCaffrey, J A a

a MATER MISERICORDIAE UNIVERSITY HOSPITAL (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUOROURACIL; FOLINIC ACID; MINOCYCLINE; OXALIPLATIN; PANITUMUMAB;

AGED; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; COLORECTAL CANCER; DRY SKIN; EYELASH; HAIR DISEASE; HUMAN; HYPERTRICHOSIS; LETTER; LUNG METASTASIS; MALE; MEDIASTINUM METASTASIS; PARONYCHIA; RASH; TRICHOMEGALY;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; EYELASHES; FLUOROURACIL; HUMANS; HYPERTRICHOSIS; MALE; ORGANOPLATINUM COMPOUNDS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 70350148377 PISSN: 15330028 EISSN: None Source Type: Journal
DOI: 10.3816/CCC.2009.n.040 Document Type: Letter

Times cited : (7)

References (8)

1
- 33746920516
- Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patients
- Roe E, Garcia Muret MP, Marcuello E, et al. Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients. J Am Acad Dermatol 2006; 55:429-437
- (2006) J Am Acad Dermatol , vol.55 , pp. 429-437
- Roe, E.¹ Garcia Muret, M.P.² Marcuello, E.³

2
- 27144459674
- Trichomegaly of the eyelashes following treatment with cetuximab
- Bouché O, Brixi-Benmansour H, Bertin A, et al. Trichomegaly of the eyelashes following treatment with cetuximab. Ann Oncol 2005; 16:1711-1712
- (2005) Ann Oncol , vol.16 , pp. 1711-1712
- Bouché, O.¹ Brixi-Benmansour, H.² Bertin, A.³

3
- 62449226157
- Trichomegaly of the eyelashes following treatment with cetuximab
- Vaccaro M, Pollicino A, Barbuzza O, et al. Trichomegaly of the eyelashes following treatment with cetuximab. Clin Exp Dermatol 2009; 34:402-403
- (2009) Clin Exp Dermatol , vol.34 , pp. 402-403
- Vaccaro, M.¹ Pollicino, A.² Barbuzza, O.³

4
- 48249086178
- Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody)
- Foerster CG, Cursiefen C, Kruse FE. Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea 2008; 27:612-614
- (2008) Cornea , vol.27 , pp. 612-614
- Foerster, C.G.¹ Cursiefen, C.² Kruse, F.E.³

5
- 34548357272
- Eye complications of cetuximab therapy
- Melichar B, Nemcová I. Eye complications of cetuximab therapy. Eur J Cancer Care (Engl) 2007; 16:439-443
- (2007) Eur J Cancer Care (Engl) , vol.16 , pp. 439-443
- Melichar, B.¹ Nemcová, I.²

6
- 58849085997
- Progressive trichomegaly
- Vano-Galvan S, Moreno-Martin P, Jaén P. Progressive trichomegaly. Neth J Med 2009; 67:35-36
- (2009) Neth J Med , vol.67 , pp. 35-36
- Vano-Galvan, S.¹ Moreno-Martin, P.² Jaén, P.³

7
- 0038163630
- Epidermal growth factor receptor inhibition induces trichomegaly
- Dueland S, Sauer T, Lund-Johansen F, et al. Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncol 2003; 42:345-346
- (2003) Acta Oncol , vol.42 , pp. 345-346
- Dueland, S.¹ Sauer, T.² Lund-Johansen, F.³

8
- 49149087664
- Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib
- Braiteh F, Kurzrock R, Johnson FM. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. J Clin Oncol 2008; 26:3460-3462
- (2008) J Clin Oncol , vol.26 , pp. 3460-3462
- Braiteh, F.¹ Kurzrock, R.² Johnson, F.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.